Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
Researchers confirmed that cytoplasmic contents could be extracted in a pressure...
Trung Huynh, an analyst with RBC Capital Markets, has projected Foundayo will re...
Researchers developed an injectable hemostatic microgel to help reduce bleeding ...
By combining CRISPR screening with epigenetic targeting, scientists identified a...
GATC Health says that an AI-driven in silico multi-omics approach shaves time of...
The team engineered vertical micropillars—each tens of times thinner than a huma...
The field of bleeding disorders has seen monumental transformation. For many pat...
Antibody-drug conjugates (ADCs) constitute a rapidly evolving class of targeted ...
In this Thought Leader article, Campbell Bunce, PhD, CSO of Abzena writes about ...
Antibody-drug conjugates (ADCs) have evolved from an elegant scientific concept ...
Today’s organoid companies underscore proof points in the ability to model compl...
In this Point of View column, Mike Garrett, CEO of Taconic Biosciences, explores...
Researchers developed novel, first-in-class drugs that inhibit both HIF-1 and HI...
Researchers developed a method to assemble n-doped poly(benzodifurandione) (n-PB...
For the genomics community February means the season of big announcements as the...
The past year marked a proverbial inflection point for organoid models designed ...
